Clinical guideline for the treatment of autoimmune neuromuscular diseases by intravenous human immunoglobulin and therapeutic plasma exchange - approved by the CNS Committee on September 17, 2010

Domů » Recommended practices » Recommended practices » Clinical guideline » Clinical guideline for the treatment of autoimmune neuromuscular diseases by intravenous human immunoglobulin and therapeutic plasma exchange – approved by the CNS Committee on September 17, 2010

Print Share